Most Active InvestorsFind investorsBlogPricing
Start for free
Start for free
Charles River Laboratories International logo

Charles River Laboratories International

North America, Massachusetts, United States, Wilmington

Description

Charles River Laboratories International is a pharmaceutical company that offers laboratory products and services for drug discovery.

Investor Profile

Charles River Laboratories International has backed more than 12 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 17% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Seed rounds (top funding stages).
  • Majority of deals are located in United States, Canada, France.
  • Strong thematic focus on Biotechnology, Life Science, Health Care.

Stage Focus

  • Series A (33%)
  • Series B (25%)
  • Seed (17%)
  • Series Unknown (17%)
  • Series C (8%)

Country Focus

  • United States (42%)
  • Canada (17%)
  • France (17%)
  • Ireland (17%)
  • United Kingdom (8%)

Industry Focus

  • Biotechnology
  • Life Science
  • Health Care
  • Therapeutics
  • Medical
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Software
  • Manufacturing
  • Commercial
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Charles River Laboratories International frequently co-invest with?

Fonds de solidarité FTQ
Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 2
Fraser
Fraser
Europe, England, United Kingdom, London
Co-Investments: 2
Amplitude Venture Capital
Amplitude Venture Capital
North America, Quebec, Canada, Montréal
Co-Investments: 2
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
A
ATUM
North America, California, United States, Newark
Co-Investments: 2
Ampersand Capital Partners
Ampersand Capital Partners
North America, Massachusetts, United States, Wellesley
Co-Investments: 2
Verve Ventures
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Kurma Partners
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Dynamk Capital
Dynamk Capital
North America, New York, United States, New York
Co-Investments: 2
Alloy Therapeutics
Alloy Therapeutics
North America, Massachusetts, United States, Waltham
Co-Investments: 2

Which angels does Charles River Laboratories International often collaborate with?

MA
Milad Alucozai
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Charles River Laboratories International?

Deciphex

Glasnevin, Dublin, Ireland

Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.

Artificial Intelligence (AI)Health DiagnosticsSoftware
Series CJan 7, 2025
Amount Raised: $32,202,774
Ability biologics

Ville-marie, Quebec, Canada

Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..

BiotechnologyLife Science
SeedJun 18, 2024
Amount Raised: $6,000,000
Ability biologics

Ville-marie, Quebec, Canada

Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..

BiotechnologyLife Science
SeedDec 6, 2023
Amount Raised: $12,000,000
Vernal Biosciences

Burlington, Vermont, United States

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

BiotechnologyLife ScienceMedical
Series AJun 27, 2023
Amount Raised: $20,000,000
iVexSol

Lexington, Massachusetts, United States

IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.

Manufacturing
Series AJan 26, 2023
Amount Raised: $23,800,000
Wheeler Bio

Oklahoma City, Oklahoma, United States

Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

BiotechnologyLife ScienceTherapeutics
Series AOct 4, 2022
Amount Raised: $31,000,000
Vernal Biosciences

Burlington, Vermont, United States

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

BiotechnologyLife ScienceMedical
Series AJun 2, 2022
Amount Raised: $21,000,000
Deciphex

Dublin, Dublin, Ireland

Deciphex uses digital pathology and AI to address the pathology productivity gap

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsSoftware
Series BMay 19, 2022
Amount Raised: $11,500,000
PathoQuest

Paris, Ile-de-France, France

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

BiotechnologyHealth CareTherapeutics
Series BNov 9, 2021
Amount Raised: $17,391,748
bit.bio

Cambridge, Cambridgeshire, United Kingdom

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

BiotechnologyCommercialHealth Care
Series BNov 5, 2021
Amount Raised: $103,000,000

Find More Investors Like Charles River Laboratories International

Discover similar investors in our database and build your perfect investor list.

series_a InvestorsInvestors in WilmingtonBrowse All InvestorsTop Investors

Need help with your fundraising strategy?Read our fundraising guides

Decorative background shape
Decorative background shape

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator

Investors By Location

San FranciscoNew York CityBostonLos AngelesChicagoLondonParisIndiaSingaporeTel Aviv

Investors By Stage

Angel InvestorsPre-Seed InvestorsSeed InvestorsSeries A InvestorsSeries B InvestorsSeries C InvestorsSeries D Investors